Typicality: | 0.551 |
Saliency: | 0.440 |
from anvisa | 12 | location |
in the near future | 11 | temporal |
from the fda | 10 | other |
product → receive → approval | 80 |
product → have → approval | 39 |
product → get → approval | 13 |
product → received → approval | 13 |
product → gain → approval | 11 |
product → be granted → approval | 7 |
product → undergo → approval | 5 |
product → meet → approval | 4 |
negative | neutral | positive |
0.136 | 0.593 | 0.272 |
Raw frequency | 172 |
Normalized frequency | 0.440 |
Modifier score | 0.850 |
Perplexity | 466.605 |